Slåtsve Arne Martin, Ravna Aina Westrheim, Lyså Roy Andre, Sager Georg
Forskningsgruppe for medisinsk farmakologi og toksikologi, Institutt for medisinsk biologi, Det helsevitenskapelige fakultet, Universitetet i Tromsø, Norway.
Tidsskr Nor Laegeforen. 2011 Jun 3;131(11):1084-7. doi: 10.4045/tidsskr.10.0675.
Drugs must be transported to reach the site of action and to be removed from the body. Several proteins within the large family of ABC transporters (ATP-binding domain), are important for pharmacokinetics. In this review article we present, from a clinical point of view, ABC transporters that are known to be important for basic and clinical pharmacology.
This overview is based on literature identified through a non-systematic search in PubMed and on results from our own work.
Members of the subfamilies ABCB and ABCC, are most known for contributing to multidrug resistance towards cytostatic and antibiotic drugs. ABCB1 (P-glycoprotein) is shown to form a functional intestinal barrier and the blood-brain barrier by pumping out potentially toxic substances. More recent research indicates that ABC transporters play an important role in absorption, distribution and elimination of many drugs and that their function is dependent on the individual genotype.
Individualized therapy may become feasible when more knowledge about ABC transporters is available.
药物必须被转运至作用部位并从体内清除。ABC转运蛋白大家族(ATP结合域)中的几种蛋白质对药代动力学很重要。在这篇综述文章中,我们从临床角度介绍了已知对基础和临床药理学很重要的ABC转运蛋白。
本综述基于通过在PubMed中进行非系统检索所确定的文献以及我们自己的研究结果。
ABCB和ABCC亚家族的成员因导致对细胞毒性药物和抗生素的多药耐药性而最为人所知。ABCB1(P-糖蛋白)通过泵出潜在有毒物质形成功能性肠屏障和血脑屏障。最近的研究表明,ABC转运蛋白在许多药物的吸收、分布和消除中起重要作用,并且它们的功能取决于个体基因型。
当获得更多关于ABC转运蛋白的知识时,个体化治疗可能变得可行。